Completed Access to Information Requests

About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Current Search

Report Type

Organization

Disposition

Year

Month

Found 199 record(s)

Req # A-2021-000457

Adverse Drug Reactions (ADRs) for Fluanxol. Report numbers: E2B_03473101, E2B_03452584, E2B_03468325, E2B_03452309, E2B_03473112, E2B_03346324, E2B_03464442, E2B_03468319, E2B_03462664, E2B_03462669, E2B_03464489, E2B_03468326, E2B_03464469, E2B_03459508, E2B_03347432, E2B_03462681, E2B_03464459, E2B_03464468, E2B_03459138, E2B_03459562.

Organization: Health Canada

517 page(s)
October 2021

Req # A-2021-000520

Adverse Drug Reactions (ADRs). Report numbers: E2B_02722097, E2B_02240279, E2B_02239685, E2B_02748923, E2B_02239686, E2B_02799660, E2B_02239680, E2B_02245744, E2B_02239374, E2B_02724246, E2B_01852440, 000938123, 000737490, 000936327, 000918578, 000926442, E2B_02669645.

Organization: Health Canada

131 page(s)
October 2021

Req # A-2021-000536

Adverse Drug Reaction (ADR) for DESOXIMETASONE. Report number: E2B_03755267.

Organization: Health Canada

75 page(s)
October 2021

Req # A-2021-000633

Adverse Drug Reactions (ADRs) for METFORMIN HYDROCHLORIDE. Report numbers: E2B_03482740, E2B_02691752.

Organization: Health Canada

53 page(s)
October 2021

Req # A-2021-000660

Adverse Drug Reaction (ADR) for PREDNISONE. Report number: E2B_03501659.

Organization: Health Canada

14 page(s)
October 2021

Req # A-2021-000661

Adverse Drug Reactions (ADRs) for SARILUMAB. Report numbers: E2B_03494103, E2B_03491796.

Organization: Health Canada

174 page(s)
October 2021

Req # A-2021-000671

Adverse Drug Reactions (ADRs) for METOLAZONE. Report numbers: E2B_03417586, E2B_03432787, E2B_03498949, E2B_03498950, E2B_03498957, 000926929.

Organization: Health Canada

99 page(s)
October 2021

Req # A-2021-000673

Adverse Drug Reactions (ADRs) for HYDROCHLOROTHIAZIDE, IRBESARTAN. Report numbers: 000919820, E2B_03378419, E2B_03503605.

Organization: Health Canada

49 page(s)
October 2021

Req # A-2021-000700

Adverse Drug Reactions (ADRs). Report numbers: E2B_03496486, E2B_03092641.

Organization: Health Canada

22 page(s)
October 2021

Req # A-2021-000711

Adverse Drug Reactions (ADRs) for Emend. Report numbers: 000721787, 000724592, 000724885, 000726049, E2B_02278629, E2B_02542491, 000722181, E2B_02326951, 000727291, 000727297, E2B_02571340.

Organization: Health Canada

147 page(s)
October 2021
Date modified: